Papers by Shirin Moarefian
Molecular Genetics and Metabolism, 2021
Objective: To investigate the outcomes of macrosomia and compare the risk factors associated with... more Objective: To investigate the outcomes of macrosomia and compare the risk factors associated with neonatal and maternal complications between mothers with gestational diabetes (GDM) and Non-GDM mothers, and determine whether it is important to screen for GDM before birth. Methodology: We sampled the venous blood of the mothers of 120 macrosomic neonates in the
Biomedical Research-tokyo, 2017
Objectives: The aim of this was to investigate the effect of letrozole (an aromatase inhibitor) o... more Objectives: The aim of this was to investigate the effect of letrozole (an aromatase inhibitor) on the Predicted Adult Height (PAH) in boys with constitutional delay of growth and puberty. Methods: In this clinical trial, the boys with constitutional delay of growth and puberty referred to Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences. Tehran was studied. Patients were treated with letrozole (letrofome, Iran Hormone Manufacturing Co., Tehran, Iran) at a dose of 2.5 mg for one year and then discontinued for 6 months and patients were followed up. Results: During one year taking letrozole, bone age was progressed from 12.49 ± 0.9 y to 13.18 ± 0.7 y and 13.64 ± 0.7 at 6 months after discontinuation. PAH at baseline was 172.5 ± 5.4 cm and after 12 and 18 months was 175.2 ± 4.3 and 174.9 ± 5.4 cm, respectively. PAH mean difference at baseline and 12th month was 2.8 cm (P=0.02), and at 12th and 18th months was -0.3 cm (P=0.70). I...
European Psychiatry, 2014
Iranian journal of pediatrics, 2013
Uploads
Papers by Shirin Moarefian